APA

Kaltenböck A., Dubischar-Kastner K., Eder G., Jilg W., Klade C., Kollaritsch H., Paulke-Korinek M., von Sonnenburg F., Spruth M., Tauber E., Wiedermann U. & Schuller E. (20090813). Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study. : Vaccine.

Chicago

Kaltenböck A, Dubischar-Kastner K, Eder G, Jilg W, Klade C, Kollaritsch H, Paulke-Korinek M, von Sonnenburg F, Spruth M, Tauber E, Wiedermann U and Schuller E. 20090813. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study. : Vaccine.

Harvard

Kaltenböck A., Dubischar-Kastner K., Eder G., Jilg W., Klade C., Kollaritsch H., Paulke-Korinek M., von Sonnenburg F., Spruth M., Tauber E., Wiedermann U. and Schuller E. (20090813). Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study. : Vaccine.

MLA

Kaltenböck A, Dubischar-Kastner K, Eder G, Jilg W, Klade C, Kollaritsch H, Paulke-Korinek M, von Sonnenburg F, Spruth M, Tauber E, Wiedermann U and Schuller E. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study. : Vaccine. 20090813.